INTRODUCTION
Therapeutic strategies to protect the ischemic myocardium have been studied extensively.
Reperfusion is the definitive treatment for acute coronary syndromes, especially acute myocardial infarction; however, paradoxically, the act of reperfusing the ischemic area can itself induce additional damage and can affect cardiac function.
Ischemic preconditioning (Pre) of myocardium is a well described adaptive response in which brief exposure to ischemia/reperfusion (I/R) before sustained ischemia markedly enhances the ability of the heart to withstand a subsequent ischemic insult. The application of brief repetitive episodes of I/R at the immediate onset of reperfusion, which has been termed "postconditioning" (Post) reduces the extent of reperfusion injury, in some cases equivalent to that observed with Pre.
Pre and Post confer remarkable cardioprotection in a variety of species, including humans.
Although several studies have reported that the effectiveness of Pre may be influenced in some disease states such as hypertension, diabetes, heart failure, hyperlipidemia, atherosclerosis, etc.
However, very little is known about the effect of Post under pathological conditions. Therefore, in the present thesis, we prepared a hyperlipidemic rat model by feeding 2% cholesterol diet, to examine the effects of hyperlipidemia on the Post-mediated cardioprotection against I/R.
There is still a considerable debate regarding the exact cellular mechanism of endogen cardioprotective phenomenona. Among several other mediators, nitric oxide (NO), oxygen free radicals, and peroxynitrite (ONOO -) play an essential role as key triggers and mediators of Pre and
Post. In this thesis we focused on the role of reactive oxygen species, especially ONOO -in the development of late Pre and Post.
ONOO -is a powerful oxidant species, which can be formed in vivo by the non-enzymatic reaction of nitric oxide and superoxide (O 2 -•) anion at an extremely rapid rate, limited only by diffusion. It is widely accepted now that enhanced ONOO -formation contributes to oxidative and nitrosative stress in a variety of cardiovascular and other pathologies. It has been shown that ONOO -is produced during the early reperfusion of ischemic hearts and that drugs which inhibit ONOO -formation or antagonize its toxicity protect the heart from reperfusion injury. In contrast, increasing evidence suggests that physiological levels of ONOO -may act as a regulator of several physiological functions. Endogenous ONOO -has been shown to trigger ischemic stress adaptation of the rat myocardium, and to activate stress response pathways.
ONOO -was reported to activate some full length matrix metalloproteinase (MMP) zymogens.
MMPs, a family of zinc-dependent endopeptidases, are implicated in a number of pathological including I/R injury in the heart. Acute release of MMP-2 during reperfusion after ischemia contributes to cardiac mechanical dysfunction. However, their role in late Pre is unknown.
AIMS

Study 1
To investigate the role of NO and peroxynitrite-MMP signalling in the development of late Pre in rats in vivo.
Study 2
A) To study the role of ONOO in rat hearts subjected to Post protocol ex vivo.
B) To examine whether experimental hyperlipidemia induced by cholesterol-enriched diet interferes with the cardioprotective effect of Post.
MATERIALS AND METHODS
Study 1
Animals and experimental groups
Male Wistar rats weighing 300-350 g were used throughout the experiments without any treatment. Animals were preconditioned by 5 consecutive cycles of 4-min ischemia and 4-min reperfusion in vivo. 24 hours after the Pre protocol, 30-min test-ischemia followed by 180-min reperfusion was performed. The control group was subjected to the same procedure without Pre protocol. To measure infarct size after coronary occlusion, hearts were isolated and perfused for 5 min in a Langendorff system to wash out the blood, then the coronary artery was re-occluded and the hearts were perfused with 0.1% Evans-blue. After Evans-blue staining, hearts were frozen, cut into slices and incubated in 1% 2,3,5-triphenyl-tetrazolium chloride for 10 minutes at 37ºC. The slices were scanned and the size of the infarcted area related to the area at risk was determined by computer planimetry.
For investigation of the biochemical parameters and gene expression changes during the development of late Pre, additional experimental groups were generated in separate experiments. A group of animals without any treatment served as 0h control. Four separate groups were preconditioned and 3, 6, 12, or 24 hours after the Pre protocol the hearts were isolated, perfused for 5 min on a Langendorff system to remove blood and frozen in liquid nitrogen. Four separate sham operated control groups undergone the same procedure as the preconditioned groups, but no occlusion was performed with the suture in these groups, then 3, 6, 12 and 24 hours later the hearts were sampled. The frozen hearts were powdered and homogenized in four volumes of ice-cold homogenization buffer with an ultrasonic homogenizer.
Finally, after evaluation of the biochemical parameters in the experimental groups, to verify if late Pre-induced inhibition of MMPs has a causative role in the reduction of infarct size, in separate experiments, 30-min test ischemia followed by 120-min reperfusion was applied after treatment with 1.5 µmol kg -1 ilomastat, a non-selective MMP inhibitor, and vehicle, respectively.
Ilomastat and its vehicle were administered 5 min before the coronary occlusion and at the 10th and 25th min of ischemia as well as at the 10th min of reperfusion to maintain its plasma level based on the half life of the molecule.
Measurement of cardiac NO metabolism
To examine the role of NO and NOS in late Pre, NO content of ventricular tissue was measured using electron spin resonance (ESR) spectroscopy after in vivo spin trapping with the NO-specific Fe 2+ -diethyl-dithiocarbamate. To estimate endogenous enzymatic NO production, 
Measurement of enzymatic O 2 -• production and degradation
In situ detection of O 2 -• anion was performed by confocal laser scanning microscopy using a fluorescent dye dihydroethidium. Activities of xanthine oxidoreductase (XOR) and NADPH oxidase, major sources of O 2 -• in rat hearts were determined from ventricular homogenates. XOR activity was determined by a fluorometric kinetic assay based on the conversion of pterine to isoxanthopterine. NADPH-stimulated O 2 -• production in freshly prepared ventricular homogenates was assessed by a lucigenin-enhanced chemiluminescence method. Total activity of superoxide dismutase (SOD), a major enzyme converting O 2 -•to H 2 O 2 , was measured by a spectrophotometric assay using a kit.
Measurement of 3-nitrotyrosine, a marker of ONOO -
To investigate the role of ONOO -, we measured free 3-nitrotyrosine content as a marker of ONOO -formation by enzyme-linked immunosorbent assay (ELISA) from the myocardium. ONOO -promotes nitration of phenolic compounds such as tyrosine, the nitration of which leads to the formation of stable product, 3-nitrotyrosine.
Zymographic analysis of MMP activity
Myocardial MMP-2 and MMP-9 activities heart ventricular was homogenized in absence of any protease inhibitor. Proteins were separated on gelatine gel. Following electrophoresis gels were washed with 2.5% Triton X-100 and incubated for 24 at 37°C in incubation buffer. Gels were then stained with 0.05% Coomassie Brilliant Blue (G-250; Sigma-Aldrich) in a mixture of methanol/acetic acid/water and destained in aqueous 4% methanol/8% acetic acid (v/v).
Gelatinolytic activities were detected as transparent bands against the dark-blue background.
Zymograms were digitally scanned, and band intensities were quantified.
Quantitative real-time PCR
Quantitative real-time PCR (QRT-PCR) was performed with gene-specific primers using SybrGreen protocol to assess expression changes of NOS, MMP and TIMP genes. Relative expression ratios were normalized to β-actin. Nontemplate control sample was used for each PCR run to check the genomic DNA contaminations of cDNA template. Analysis of results was done using Pfaffl method. With the use of this calculation method, differences between the amplification efficiencies of reactions could be corrected.
Study 2 Animals and experimental groups
Six-week old male Wistar rats were fed normal or 2% cholesterol-enriched rat chow for 12
weeks. At the conclusion of the experimental diet period, animals were anesthetized with diethyl ether and given 500 U/kg heparin. Hearts were isolated and perfused with Krebs-Henseleit buffer with constant pressure according to Langendorff. Regional ischemia was induced by 30 min coronary occlusion followed by 120 min reperfusion. Post was induced by six or twelve consecutive cycles of 10 s coronary occlusion and 10 s reperfusion immediately at the onset of reperfusion.
Electrocardiogram was monitored during the study to measure heart rate and incidence of At the end of the 120-min reperfusion period, infarct size was measured as described above.
For biochemical analysis, hearts from control and cholesterol-fed groups were subjected to 30 min coronary occlusion followed by 5 min reperfusion with or without Post, and used for 3-nitrotyrosine measurements.
Measurement of 3-nitrotyrosine, a marker of ONOO -
Left ventricular tissue was sampled, homogenized, and used for 3-nitrotyrosine measurements by ELISA as mentioned above and by Western Blot analysis. Homogenized heart tissue for Western Blot analysis was centrifuged. Protein concentrations of supernatants were measured by the bicinchoninic acid assay. Equal amounts (20 µg) of proteins were separated by 6 10% SDS-PAGE and transferred to nitrocellulosemembrane, then the blot was blocked in Tris buffered saline/Tween 20 supplemented with 5% nonfat dry milk overnight. The primary 3-nitrotyrosine antibody was used at the manufacturer-recommended dilution. The membrane was developed with an enhanced chemiluminescence kit, exposed to X-ray film, and scanned. Band density was calculated by integrating the area (pixels x intensity, expressed in arbitrary units). By this method, we detected the degree of nitrosylation of tyrosine side chains of proteins, since low-molecular weight free 3-nitrotyrosine is eliminated in the SDS-PAGE.
RESULTS
Study 1
In control hearts ischemia and reperfusion resulted in a large infarction. When Pre was applied before ischemia, infarct size significantly decreased showing the protective effect of late Pre against acute I/R injury.
Ca 2+ -dependent NOS activity and expression levels of endothelial and neuronal NOS remained unchanged. However, Ca 2+ -independent NOS activity increased gradually after the Pre protocol and at 12h the elevation reached the level of significance then further increased by 24h.
iNOS mRNA content measured at 24h was also increased significantly as compared to the sham operated group, however, gene expression of other NOS isoforms remained unchanged. Despite the increased iNOS expression and activity, NO signal did not change during the development of late Pre.
In cardiac superoxide metabolism, we observed a gradual increase of XOR and NADPH oxidase activities in both preconditioned and sham operated groups as compared to the 0h control group, however, there was no difference between Pre and sham operated groups. A significant decrease of myocardial total SOD activity is shown in the Pre group 24h after the Pre protocol, when compared to 0h control and to 24h sham operated group, respectively. We compared myocardial superoxide content in Pre and sham operated groups and found a significant elevation 24h after the Pre protocol, when measured cardiac superoxide by dihydroethidium staining.
ONOO -generation was attenuated significantly when compared to sham operated group 24h after the Pre. Characteristic MMPs of the myocardium was performed by zymography. Both, MMP-9 and MMP-2 activities have shown a significant reduction 24h after the Pre protocol compared to the sham operated animals. Ischemic late Pre resulted in a decrease in the gene expression of MMP-2, however, the amount of MMP-9 mRNA was increased. Gene expression of tissue inhibitor of metalloproteinases TIMP1, TIMP2 and TIMP4 were not changed, however, TIMP-3 mRNA showed a significant decrease in the Pre group, when compared to sham operated group.
To verify if Pre-induced inhibition of MMP activity has a causative role in the reduction of infarct size, Ilomastat, a non-selective MMP inhibitor was used. Ilomastat (1.5 μmol kg -1 ) given 5 min before ischemia followed by infusion during ischemia and the first 10 min of reperfusion to maintain plasma concentration, decreased infarct size significantly as compared to the vehicle treated animals.
Study 2
Post with 6x10 s cycles significantly decreased infarct size and the incidence of VF in hearts of rats with normolipidemic diet and was lost in hyperlipidemic hearts. To test if a more potent Post stimulus could protect the hyperlipidemic heart, in a separate set of experiments, Post with 12x10 s cycles of brief ischemia-reperfusion was applied. However, this Post protocol failed to reduce infarct size not only in hyperlipidemic but also in normolipidemic hearts.
Post significantly increased peroxynitrite-induced 3-nitrotyrosine formation in normolipidemic hearts, but not in hyperlipidemic conditions at the 5th min of reperfusion.
To test if the early increase in nitrosative stress signal observed in normolipidemic animals is a necessary trigger for the development of cardioprotection by Post, in separate experiments, Post was induced in the presence of a ONOO -decomposition catalyst FeTPPS in normolipidemic animals. Although FeTPPS did not affect infarct size significantly in the nonpostconditioned group, it abolished the infarct size-limiting effect of Post.
DISCUSSION
In the present study 1 we showed that infarct size significantly decreased in response to the late Pre. We have confirmed that the cardioprotective effect of ischemic late Pre was accompanied by the induction of iNOS as described previously by several studies. In our present study, surprisingly, iNOS activation did not lead to increased NO level in the myocardium as measured by electron spin resonance spectroscopy 24 h following the Pre stimulus. These findings show that the role of iNOS in late Pre may be not related to increased NO production. This is further supported by the finding that 1400W, a selective iNOS inhibitor, did not decrease cardiac NO content at late Pre in our present study.
Many of the physiologic actions of NO are mediated through ONOO -, the reaction product of NO and superoxide. Therefore, we examined myocardial levels of superoxide and ONOO -as well as the expression and activity of the enzymes involved in superoxide production and its elimination. We have found here a markedly increased superoxide level in the myocardium 24 h after Pre as compared to the non-preconditioned group. Neither XOR activity nor NADPH oxidase activities were changed, however, SOD activity was decreased 24 h after the Pre stimulus as compared to the non-preconditionined controls. These results show that the source of increased myocardial superoxide can be a decreased activity of SOD. Moreover, it is well known that iNOS is able to produce superoxide in certain circumstances e.g. absence of tetrahydrobiopterin and/or L-arginine and altered ratio of reactive oxygen and nitrogen species. Therefore, since NO production was not increased in the present study, increased iNOS activity could be the source of increased superoxide level during late Pre. We have previously shown that ONOO -may trigger classic ischemic Pre and subsequent cycles of ischemia/reperfusion result in a gradual decrease in ONOO -formation. In Study 1 we measured cardiac 3-nitrotyrosine levels as a marker of cardiac ONOO -generation and showed for the first time that late Pre significantly diminishes myocardial
It is known that ONOO -at low concentrations contributes to the beneficial effects of Pre on ischemia in isolated rat hearts. However, no attempt has been made so far to measure cardiac 
